{
    "title": "Astrazeneca hikes dividend for first time in a decade as Covid jab drives record sales",
    "url": "https://www.dailymail.co.uk/money/markets/article-10500053/Astrazeneca-hikes-dividend-Covid-jab-drives-record-sales.html",
    "date": "2022-02-10",
    "keywords": [
        "year",
        "share",
        "dividend",
        "jab",
        "astrazeneca",
        "growth",
        "fund",
        "time",
        "cent",
        "covid19",
        "globe",
        "farxiga",
        "revenue",
        "money",
        "diy",
        "platform",
        "firm",
        "increase",
        "surge",
        "target",
        "soriot",
        "group",
        "investment",
        "account",
        "fee",
        "decade",
        "record",
        "pharma",
        "giant",
        "vaxzevria",
        "pfizer",
        "vaccine",
        "boost",
        "university",
        "oxford",
        "basisthe",
        "move",
        "world",
        "moneyspinnerastrazeneca",
        "blockbuster",
        "tagrisso",
        "lynparza",
        "calquence",
        "cancer",
        "treatment",
        "medicine",
        "fasenratagrisso",
        "alison",
        "pledge",
        "bid",
        "pan",
        "loan",
        "revolution",
        "bank",
        "boss",
        "uturn",
        "article",
        "trial",
        "result",
        "payout",
        "company",
        "swung",
        "loss",
        "profit",
        "percentage",
        "takeover",
        "swoop",
        "term",
        "profitability",
        "price",
        "triple",
        "charge",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}